E-Mail Alert

Add your e-mail address to receive forthcoming issues of this journal:

Journal Browser

Journal Browser

Pharmaceuticals Events Announce Your Event Here

1–30 November 2018 4th International Electronic Conference on Medicinal Chemistry

Electronic conference (Online)

The aim of the Conference is to gather researchers from all over the world and encourage discussions on any scientific field related to drug discovery and development. By posting presentations, videos, or posters disclosing your recent outstanding results, take advantage of the Conference to promote your work among thousands of your peers. Participation, as an author or a visitor, is ABSOLUTELY FREE; simply register on the home page.


15–30 November 2018 The 3rd International Electronic Conference on Metabolomics

Electronic conference (Online)

The conference will be held online from 15–30 November 2018, enabling you to present your latest research to the scientific community and to have the opportunity to participate in fruitful exchanges of information with academic and industrial groups from all over the world. It is absolutely free of charge to participate as an author or a visitor; all you need to do is create an account on the home page. After the conference, the authors are also welcome to submit an extended version of the proceeding papers to the Special Issue of Journal Metabolites with 20% discount of the APC charges.


23 November 2018 MedChem 2018

Namur, Belgium

The Medicinal Chemistry Divisions of the two Belgian Chemical Societies, Société Royale de Chimie (SRC) and Koninklijke Vlaamse Chemische Vereniging (KVCV), are organising every year an international one-day symposium with the aim to update participants on selected areas of pharmaceutical research by specialists in their respective field.

MedChem 2018 will be held on Friday November 23, 2018, in Namur. The programme of the day will include six invited lectures and three oral communications selected from submitted abstracts.

In recent years, this symposium has been gathering around 170 participants at each edition, half from universities, half from industry, both from Belgium and surrounding countries. It has been focussing on topics such as:

The Many Pharmacotherapeutic Faces of Nucleosides and Oligonucleotides (2017)
PET & Imaging : From Chemistry Lab to Clinical Applications (2016)
New Vistas in GPCR Research: the Dawn of an Exciting Drug Discovery Era? (2014)
Constrained Peptides and Macrocycles – New Opportunities for Drug Discovery (2013)
From Rapid Dissociation to Irreversible Inhibition – Optimisation of Drug-Target Residence Time (2012)
Emerging Targets and Treatments: Opportunities and Challenges for Drug Design (2011)
Does size matter? Beyond small molecule therapeutics: challenges and success stories (2009)


23–25 January 2019 13th National Congress of the Austrian Society of Nuclear Medicine & Molecular Imaging

Zell am See, Austria

The 13th National Congress of the Austrian Society of Nuclear Medicine & Molecular Imaging will take place from January 23 – 25, 2019 in the Ferry Porsche Congress Center (FPCC) in Zell am See, Austria.

The congress is organized by the Austrian Society of Nuclear Medicine & Molecular Imaging (OGNMB) and will be held under the auspices of the EANM.

Authorities with experience in basic science as well as clinicians from Austria will come together to share their experience with us. Lectures will cover the full range of diagnosis and treatment in molecular imaging. Furthermore, new types of session will be introduced to make this congress attractive to nuclear medicine physicians, physicists, radiopharmacists and technologists.

The lecture hall, the poster walk and the exhibition area are directly located on the same floor. This layout ensures and provides easy accessibility as well as excellent face – to – face communication between exhibitors and congress participants.

We would highly appreciate your participation and we are looking forward to seeing you in Zell am See in January, 2019.


25–26 March 2019 The 2nd Annual Formulation & Drug Delivery USA Congress

San Diego, USA

Oxford Global is proud to present the 2nd Annual Formulation & Drug Delivery USA Congress to be held on 25 – 26 March 2019, San Diego, USA. Over 200 delegates representing leading pharmaceutical organisations, biotech companies internationally renowned research & academic institutions will be present.
Over 35 case studies and presentations focused on exploring challenges and solutions in formulation and drug delivery of small and large molecules.
View Agenda: https://bit.ly/2u1JouQ

4 interactive streams:
• Large Molecule Drugs Formulation
• Advances in Small Molecule Drug Delivery
• Small Molecule Drug Formulation
• Large Molecule Drug Delivery
With featured streams on:
• Nanoformulation & Delivery
• Delivery for RNA-based therapeutics

2019 Free Live Webinar
Selection and Management of Contract Development and Manufacturing Organizations
Vadim Klyushnichenko, California Institute for Biomedical Research (Calibr), on 1st February 2019, 9am PST / 5pm BST.
Register for free here: https://bit.ly/2NV7P8p
Can't make the dates? Still register and receive the recording afterwards.

For further information on the congress and to receive prices and booking details, please contact Guillaume Alonso at or call +44 (0)1865 248 455


15–17 May 2019 2nd Molecules Medicinal Chemistry Symposium – Facing Novel Challenges in Drug Discovery

Barcelona, Spain

It is with great pleasure that I announce the 2nd Molecules Medicinal Chemistry Symposium (MMCS): Facing Novel Challenges in Drug Discovery to be held in Barcelona, Spain, 15–17 May 2019.
Encouraged by the great success of the initial small-format monographic MMCS2017, the three-day MMCS2019 will grow naturally by addressing a larger audience and essentially all topics of medicinal chemistry. The MMCS2019 will be organized into a number of thematic sessions on medicinal chemistry of particularly challenging diseases, novel and revisited drug discovery approaches, and medicinal chemistry stories about recently implemented projects in any area not covered in the other sessions, from target and hit identification to hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.


3–7 June 2019 14th International Conference on the Chemistry of Selenium and Tellurium (ICCST-14)

Hotel Resort Flamingo, Santa Margherita di Pula (CA), Sardinia (Italy)

The International Conference on the Chemistry of Selenium and Tellurium (ICCST), whose first edition was held in 1971, is a well-established conference dealing with all aspects of the chemistry involving selenium and tellurium from small molecules to biomolecules, pharmacological applications and materials. The 14th edition of ICCST will be held for the first time in Italy on the 3rd-7th June 2019 at the Hotel Resort Flamingo, Santa Margherita di Pula (CA), Sardinia, Italy (Prof. Vito Lippolis Chairman, and Prof. Claudio Santi Co-Chairman). For more information see: http://convegni.unica.it/iccst-14 or write at


12–15 February 2012 4th International Conference on Drug Discovery and Therapy

Dubai, UAE

This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments in drug discovery and on new therapeutics.

This conference organized by Eureka Science with the support of the Higher Colleges of Technology, UAE, focuses on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.

After the overwhelming success of the previous conferences held in Dubai in February 2008, 2010 and 2011 (where many Nobel Laureates attended), the fourth conference promises to be a much larger event with over 500 talks delivered and 36 thematic sessions with poster presentations and an associated commercial exhibition.

Throughout the course of the four day conference, you will have the opportunity to both network and hear leaders from the international pharmaceutical, academic and clinical communities.


14–15 September 2017 31e Journées Franco-Belges de Pharmacochimie

Spa, Ardennes, Belgium

The “Journée Franco-Belge de Pharmacochimie” is a recognized annual meeting on Medicinal Chemistry. This 31 edition will be held on the 14th and 15th of September in the beautiful city of Spa located in the heart of Belgium Ardennes.

This two-day symposium aims to promote the meeting between medicinal chemists mainly from France and Belgium. The JFB are renowned for advanced science, conviviality, and outstanding opportunities for senior and young scientists to exchange knowledge.

The scientific program will include one tutorial lecture and 4 plenary lectures by internationally recognized scientists. An important part of the program is devoted to open lectures (10 oral communications) giving the opportunity for young scientists to present their research.

This year the official language for the lectures will be English. The deadline for the registration and the submission of abstracts is Monday 21th August 2017.


16–17 October 2017 Next-Generation Antibodies and Protein Analysis (2nd Edition)

Ghent, Belgium

The Next Generation Antibodies and Protein Analysis: Tools and Technologies meeting (NGAPA) in June 2015 was a great success and we are pleased to announce the 2nd edition in October, 2017. The symposium will bring together some of the most highly regarded Academics and Companies in the world with novel technologies in several sessions, with topics focused on:

Protein Modifications
Single Domain and Recombinant Antibody tools
Next-Generation Affinity Reagents
Bio-sensing and molecular interactions
Single-Cell technologies
Protein design

Catalyzed by VIB’s Technology Scouting team, the Tools and Technologies meetings focus on the front end of innovation and bring together key innovators in selected life sciences research fields. The Next-Generation Antibodies and Protein Analysis conference is set to make another world class meeting, bringing together an exciting selection of top speakers and newly emerged companies. In addition to great scientific and technology program, the conference will provide ample networking opportunities.


27–28 November 2017 The Global Medicinal Chemistry & GPCR Leaders Summit

London, UK

The summit has five tracks focusing on key issues such as optimising hit to lead quality and timescale, protein degradation, DNA Encoded libraries, GPCR’s, small molecule Immuno-oncology research, FBDD, SBDD, CADD as well as best strategies for partnerships, collaborations, outsourcing and integration of research. The Summit will provide a forum to network, learn and engage with senior representatives of leading pharmaceutical and biotech companies worldwide.


4–5 December 2017 4th Synthetic Biology & Gene Editing Congress

London, UK

The 4th Global Synthetic Biology & Gene Editing Congress is one of 4 strands that make up the 4th 4BIO Summit. The other 4BIO strands are the 5th qPCR & Digital PCR Congress, 3rd Microfluidics Congress and new for 2017 the NGS Tech & Applications Congress.

The 4BIO Summit will provide an interactive networking forum to both further develop and answer your queries through a vibrant exhibition room full of technology providers showcasing their technologies and other solutions, poster presentation sessions, expert led case study presentations and interactive Q&A sessions from a 100 + speaker faculty.


17–19 January 2018 12th National Organic Chemistry Meeting (12ENQO) and 5th National Medicinal Chemistry Meeting (5ENQT)

Coimbra, Portugal

17–19 January 2018
12th National Organic Chemistry Meeting (12ENQO) and 5th National Medicinal Chemistry Meeting (5ENQT)
Coimbra, Portugal

In January, 2018, the 12th National Organic Chemistry Meeting (12ENQO) and the 5th National Medicinal Chemistry Meeting (5ENQT) will be taking place in Coimbra, Portugal. The Divisions of Organic Chemistry and Medicinal Chemistry of the Portuguese Chemical Society (SPQ) will be responsible for the organization of this scientific meeting.

As in the previous edition of the Meeting, by bringing together, in a single event, authorities of these two important and complementary areas, new synergies are expected to arise. The interdisciplinary nature of this meeting will be reflected in an attractive program comprising Plenary Sessions, Invited Communications, Oral Communications and Poster Communications that will surely attract the interest of a vast audience. There will be plenty of time for casual discussions and exchanges of ideas among the participants.

Coimbra is a beautiful historical city in the center of Portugal. UNESCO has granted the World Cultural Heritage label to the historical center of this city. In Coimbra, we can find one of the oldest and most prestigious universities in Europe, whose students bring life and multiculturalism to the city. It is filled with amazing places, magnificent monuments and many unique traditions. Coimbra is easy to reach from both Lisbon and Porto international airports, by train and bus.

For more information, please visit the conference website at:


8–9 March 2018 Applied Bioinformatics in Life Sciences (2nd edition)

Leuven, Belgium

As an integral part of biological research, the field of bioinformatics brings forth innovative computational approaches leading to high-impact results in an increasingly data-dense environment.

After a sold-out first edition in March 2016, this second edition will feature recent developments in bioinformatics research, and highlight the power of computational biology in the fields of medical, agricultural, and biotechnology research. Renowned speakers will present how bioinformatics is applied broadly in life sciences, and shed light on the future perspectives of their research.

During four plenary sessions, the speakers will focus on the topics:

Medical Integrative Omics
Proteomics and Metabolomics
Structural Bioinformatics
Systems Biology

​Conference attendees will have ample networking opportunities besides an exciting scientific program.

Keep track of the news about ABLS by liking us on Facebook or following us on Twitter.


11–12 April 2018 Aptamers 2018

St Hilda's College, Oxford, UK

Our 5th Oxford meeting – Aptamers 2018 – will address therapeutic, diagnostic, analytical and basic research applications of aptamers and invites oral and poster abstracts from academic and industrial researchers. We particularly encourage final year doctoral students and early/mid career postdoctoral researchers/junior group leaders to submit oral abstracts, as we believe this event will provide their research excellent exposure, critical analysis by attending senior researchers and new career opportunities.

The symposium will feature:

High-impact talks, discussions & several hours of networking
Oral presentations by an international faculty of senior & junior researchers from academia & industry
Update on aptamer patents
Posters, plus flash talks by selected poster presenters
Trade exhibition
Excellent networking opportunities, & a relaxed and friendly environment

Aptamers 2018 will be co-hosted with Oligo 2018 (10th April) – 4th symposium on antisense & therapeutic oligonucleotides (separate registration required).


16–17 April 2018 5th Annual Biosimilars & Biobetters Congress

London, UK

Oxford Global Conferences are proud to present the 5th Annual Biosimilars & Biobetters Congress co-located with the 11th Annual Proteins & Antibodies Congress and the 5th Annual Peptides Congress, taking place on the 16-17 April 2018 in London.

Over 450 proteins, peptides and biosimilars delegates representing leading biotech companies, global pharmaceutical organisations and internationally renowned academic institutions

Over 20 presentations and case studies focusing on the key areas of the biosimilars industry including market access strategies, clinical development, commercialisation, manufacturing and bio-analytics

Two-day interactive conference addressing the following topics:

  • Market Access Strategies, Opportunities, Clinical Development and Commercial Challenges
  • Developing Biosimilars and Biobetters – Manufacturing and Bio-analytics 

View Agenda here: http://bit.ly/2eFkKL6

Free Pre-Congress Live Webinars

Biosimilars: Everyday Practice, Manufacturing Pre-Clinical Trials
Hosted by Katalin Egyed, International Oncology and Onco-biotechnology Business Unit Manager, EGIS Pharmaceuticals and Rafał Derlacz, Senior Project Manager, Polpharma.
Wednesday 7th February 2018 | 10am GMT

Register today for free: http://bit.ly/2xNJGbG

Biosimilars: The Cancer Patient Perspective
Hosted by Lydia Makaroff, Director, European Cancer Patient Coalition
Tuesday 13th February 2018 | 10am GMT

Register today for free: http://bit.ly/2j1vAAf

Can’t make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact a.fernandez@oxfordglobal.co.uk


13–16 May 2018 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018)

Anaheim Convention Center, California, USA

Meet Us at The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018) (Booth # 319), Anaheim, CA, USA, 13–16 May 2018

We will be attending The 20th annual Nanotech 2018 Conference & Expo (NANOTECH 2018), co-located with the TechConnect World Innovation Conference, Defense TechConnect Summit and Spring SBIR/STTR Conference. The event will attract more than 350 featured exhibitors and an expected crowd of more than 4000 attendees, including business executives, venture capitalists, politicians, s cientists and researchers from over 70 countries. Nanotech contains 38 symposiums and brings together specialists from a wide range of scientific fields, technology and business.

Representatives of the following open access journals will attend:

Journal of Functional Biomaterials
Journal of Imaging
Applied Sciences
Journal of Low Power Electronics and Applications
International Journal of Environmental Research and Public Health
Journal of Manufacturing and Materials Processing

If you will also attend this conference, please feel free to stop by our booth (Booth # 319). Our delegates look forward to meeting you in person to answer any questions you may have. For more information about the conference, please visit:


13–15 June 2018 GP2A-JFB 2018

Asnelles sur Mer (Normandie), France

The congress entitled "32èmes Journées Franco-Belges de Chimie Thérapeutique et 26èmes Conférences Européennes des Pharmacochimistes de l'Arc Atlantique", will take place between 13th and 15th June 2018 in "Les Tourelles Centre" on the beach of Asnelles-sur-Mer near Arromanches (Normandie, France).
The registration are open on : https://gp2a-jfb2018.sciencesconf.org
It is still possible to propose PhD short communications (5 min), Young Researcher communications (15 min), or Poster communications.

Numerous prizes will be awarded.

Registrations are open until April 30th 2018
All details concerning the scientific program and accommodation are available on offical webpage.


14–17 June 2018 Second International Conference on Zika Virus and Aedes Related Infections

Tallinn, Estonia

We are pleased to announce the Second International Conference on Zika Virus and Aedes Related Infections to take place in Tallinn, Estonia, June 14-17, 2018.

This unique, inter-disciplinary conference will include all Aedes related infections in addition to Zika. Aedes related infections have become a concern and continue to be a global threat with Europe being one of the affected areas. The content of this conference will include: epidemiology and clinical aspects of Aedes related infections, gynecological aspects and follow up with children born to Zika infected mothers. In addition, virology aspects, diagnostic methods, new therapy and vaccine production as well as new methods of mosquito control all will be discussed in the meeting.

Keynote Speakers:

Professor David Baud, University Hospital, Lausanne, Switzerland
Keynote lecture: Congenital Zika Syndrome: Updates and Gaps in Knowledge

Dr Celine Gossner, Surveillance and Response Support, European Centre for Disease Prevention and Control, Stockholm, Sweden
Keynote Lecture: Aedes Related Infections: European Point of View

Professor Duane J. Gubler, Duke-NUS Medical School, Singapore
Keynote Lecture: Zika and Other Aedes Transmitted Diseases, Past, Present, and Future

Professor Paul Reiter, Consultant on mosquitoes and mosquito-borne diseases, France
Keynote Lecture: New Methods for Mosquito Control

Prof Annelies Wilder-Smith, London School of Hygiene and Tropical Medicine, London, UK & WHO Initiative for Vaccine Research
Keynote Lecture: The Drama of the First Dengue Vaccine

For further details and to view the detailed scientific program please visit the conference website:


2–6 September 2018 XXV EFMC International Symposium on Medicinal Chemistry

Ljubljana, Slovenia

The XXV EFMC International Symposium on Medicinal Chemistry will continue the tradition established by these biennial symposia of covering drug discovery advances in major therapeutic areas, including the treatment of inflammatory and autoimmune diseases, infectious diseases including fungal infections, cardiometabolic diseases, neurodegenerative diseases and oncology. EFMC-ISMC 2018 will present the most recent advances in up-to-date topics like protein degradation, STING pathway, kinetics and pharmacokinetics of drug binding and PET imaging, and will tackle some out-of-the-box areas of Medicinal Chemistry including carbohydrate-based vaccines and new chemical modalities, while Chemical Biology approaches to target identification will cover the interfaces between chemistry, biology and experimental medicine. Particular emphasis will be put on first time disclosures, recent highlights in medicinal chemistry, and the impact of artificial intelligence in drug discovery.


9–13 September 2018 XXXVIII Convegno Nazionale della Divisione di Chimica Organica–CDCO2018

Milan, Italy

Il XXXVIII Convegno Nazionale della Divisione di Chimica Organica della Società Chimica Italiana si svolgerà a Milano dal 9 al 13 settembre 2018. L’organizzazione di questa edizione del Convegno è curata dalla Divisone di Chimica Organica della Società Chimica Italiana con il supporto dell’Università degli Studi di Milano e dell’Università degli Studi di Milano-Bicocca, e con la collaborazione di Federchimica e Assolombarda.
Il Convegno, come da tradizione, è aperto all’accademia, agli enti di ricerca, all’industria, alla scuola ed alle istituzioni attive in tutti i settori della chimica organica ed in quelli interdisciplinari ad essa collegati, con lo scopo di stimolare discussioni e promuovere proficui scambi scientifici.


25–28 September 2018 Fifth Annual Re-Entering Antibacterial Discovery and Development Summit

Boston, MA, USA

We are witnessing rapidly unfolding efforts to reinvigorate the antibacterial pipeline, improve antimicrobial stewardship and bring the multidrug microbial resistance under control. Industry, academia and government entities are working together on sustainable solutions for the antibiotic resistance crisis. Multidrug-resistant Gram-negative bacteria currently pose the biggest threat and attract the most attention from researchers and policy makers. Novel platforms, screening strategies and new drugs as well as new pathways for clinical development and market access are needed to overcome the current state of emergency associated with multidrug-resistant bacteria. Cambridge Healthtech Institute's 5th Annual Re-Entering Antibacterial Discovery and Development Summit is designed as a knowledge and experience exchange for the major stakeholders working in this important area. The Summit features two conferences, Antibacterial Discovery and Development (September 26-27) and Targeting Gram-Negative Pathogens (September 27-28), and several short courses.


11–12 October 2018 5th Annual Drug Discovery USA Congress

San Diego, USA

Join Oxford Global’s 5th Annual Drug Discovery USA Congress taking place on the 11-12 October 2018 in San Diego. Across the two days, over 40 expert speakers will provide you with insights into the latest technological innovations and strategic approaches in drug discovery and drug chemistry.

View Agenda: https://bit.ly/2MIXuM8

The American biopharmaceutical research sector has been a world leader in the development of new medicines over the past 30 years and it continues to drive biopharmaceutical innovation. Our conference delivers an extensive look across the development process: from drug discovery innovation and strategies to computational chemistry and informatics for drug design.
The conference will feature over 40 presentations from leading heads of the pharmaceutical industry and ensures you will benefit from the latest case studies and high level scientific debate. Topic discussion ranges across the latest validation and optimisation strategies in neuroscience, cardiology and oncology. Further talks look at approaches to phenotypic and genomic drug discovery design, as well as novel approaches to drug design: AI-based design, DNA Encoded Libraries and protein-protein interactions.
Include 4 Streams:
• Day 1 Stream 1: Drug Discovery Innovation and Strategies
• Day 2 Stream 1: Phenotypic and Genomic Drug Discovery
• Day 1 Stream 2: Computational Chemistry and Informatics for Drug Discovery
• Day 2 Stream 2:
o Part 1: Novel Approaches to Drug Design
o Part 2: DNA Encoded Libraries

For more information contact or join the congress conversation on Twitter @DrugDiscoveryUS or our LinkedIn Group: Drug Discovery & Development Network


5–10 July 2009 Drug Metabolism 2009

Holderness, NH, USA

The 2009 Gordon Research Conference on Drug Metabolism will focus on current and developing research increasing our understanding of the metabolism and disposition of drugs and xenobiotics.


31 July–1 August 2009 Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Application (SERC 2009)

National Institutes of Health, Bethesda, Maryland, USA

This conference focuses on issues related to ocular drug delivery. It will entertain an integrated approach to discussing benchmarks in drug development, delivery platform technology and proof of concept models. Faculty and students from industry, the clinic and academe will be invited to present papers and posters. Abstract submissions will be reviewed and accepted for appropriate placement in the agenda.


14–18 September 2009 Land O' Lakes Conference on Drug Metabolism/Applied Pharmacokinetics

Merrimac, WI, USA

The purpose of this four-day conference is to provide an educational forum to discuss the current issues in selecting potential new therapeutic entities for preclinical trials and current issues in drug metabolism and preclinical pharmacology.


19–22 September 2009 7th EACPT Summer School in Clinical Pharmacology and Therapeutics

Alexandroupolis, Greece

The EACPT Summer School aims to improve the knowledge and skills of young colleagues interested in Clinical Pharmacology. A broad spectrum of topics will be offered by distinguished lecturers from various European countries. These topics will include an overview of all essential knowledge in Clinical pharmacology, and also more focused lectures on Pharmacogenomics and Clinical trials in South/Eastern Europe.


27–28 October 2009 BioProduction 2009: Disposables for Biopharmaceutical Manufacturing

Barcelona, Spain

Disposables for Biopharmaceutical Manufacturing brings together the key players from across the industry to discuss the main barriers facing this market and ways to overcome them – procurement, supply chain management, scale-up, implementation, cost management, environmental risk and validation.


25–27 November 2009 Pharmacokinetics UK (PKUK 2009)

Copthorne Hotel, Birmingham, UK

PKUK was a spin out from the DMDG (Drug Metabolism Discussion Group) in the early 80s. The original idea came from Roger Metcalf, who used to head up DMPK at SK&F. It was felt at the time that DMDG was not adequately addressing the issues related to PKPD problems in the pharmaceutical industry and there was a need for a more specialized meeting on PKPD.


1–4 February 2010 2nd International Conference on Drug Discovery and Therapy

Dubai, UAE

This unique international conference provides a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about all the important international breakthrough developments on drug discovery and on new therapeutics.


20–25 April 2010 Computer-Aided Drug Design

Whistler, British Columbia

The purpose of this meeting is to stimulate progress in the methods of computer-aided drug design. This will be accomplished by bringing theory and practice into contact at a number of levels in order to highlight interesting and important practical problems waiting to be solved, and by deepening participants’ understanding of the science underlying these challenges.


25–29 April 2010 3rd Molecular Discovery Users Meeting on Novel Computational Methods for Cheminformatics, Rational Drug Design and DMPK Prediction

Gualdo Tadino ( Perugia ), Italy

We are pleased to announce the third MD Users Meeting which will be held in Perugia, Italy, from the 25th to 28th of April, 2010. The main focus of the Meeting will be on the practical use of the MD Programs in real research applications, and participants will be able to work with the latest release of each Program. They will also have a unique opportunity to evaluate and try some of the novel software projects which are currently being developed by the scientists at Molecular Discovery.


15–16 May 2010 AAPS Workshop on Strategies to Address Therapeutic Protein Drug Interactions during Clinical Development

Hilton San Francisco Union Square 333 O\'Farrell St. San Francisco, CA 94102, USA

Goals and Objectives

To provide participants with a clear understanding on how to develop strategies for assessment of TP-drug interactions.
Workshop objectives are to:

  • review preclinical tools and in vitro test systems for assessing drug interaction potential of therapeutic proteins such as cytokines and cytokine modulators,
  • provide an in-depth review of reported and documented clinically relevant TP-drug interactions,
  • discuss case studies, study designs and acceptance criteria for assessing PK and PD based TP-drug interactions in clinical studies,
  • provide participants with the skills to develop a science-driven, risk-based approach for assessing the potential of TP-drug interactions


Therapeutic proteins, such as monoclonal antibodies, cytokines, and cytokine modulators, are increasingly being combined with small molecule drugs and/or other therapeutic proteins. Limited scientific and development experience is available in assessing the potential for PK and PD interactions of these TP-drug or TP-TP combination therapies. In this workshop, industry, academic and regulatory speakers will highlight important main themes that have started to emerge for considerations in drug interaction assessment for therapeutic proteins such as: molecule type, target, indication, and disease biology. Speakers will also discuss recent reports regarding the regulation of CYP450 enzymes and transporters in inflammatory states. The use of cytokine, cytokine modulators, and immunosuppressant-containing combinations in inflammatory indications may have potential for drug interactions, in particular when therapeutic proteins are combined with narrow therapeutic range drugs. This workshop will provide the opportunity for participants to interact with industry, academic and regulatory representatives and to participate in roundtable discussions on how to arrive at a science-driven, risk-based approach for assessing the potential for TP-drug interactions.


24–25 June 2010 1st International Meeting on Pharmaceutical Sciences

Cordoba, Argentina

This conference is devoted to established topics such as advanced drug delivery systems, pharmaceutical biotechnology, micro- & nanotechnology, natural products, pharmacology and many more which will be dealt with in short oral and poster presentations. In addition, a Workshop on Pharmacy Practice and Education is going to be organized during this Meeting. As you know, education plays an extremely important role in preparing pharmacy students for several professional activities. It serves to ensure knowledge, skills, attitudes and behaviour required of pharmacists in order to contribute to communities and health systems in the best possible ways. Whether you’re a student pharmacist this Meeting will provides educational programming and networking to keep you on track in your day-to-day practice. This Meeting will give you the opportunity to generate novel ideas, practices, cultural diversity and practices, in order to promote positive changes in pharmacy education and for pharmacy to progress globally as a profession.


17–23 July 2010 WorldPharma 2010

Copenhagen, Denmark

It is our pleasure to present the programme for the 16th World Congress of Basic and Clinical Pharmacology, WorldPharma2010, to be held in Copenhagen 17-23 July 2010.

For this IUPHAR congress, basic and clinical pharmacology, kept separate for too long, have come together again for a remarriage to encompass the whole process of drug development from molecular biology to clinical practice. Here the World’s basic and clinical pharmacologists and all those dealing with the development and use of drugs will meet to discuss how we can work together to meet the need for safe and effective medicines at affordable prices.

As will be seen from the programme, WorldPharma2010 provides in depth treatment of the hottest topics in basic and clinical pharmacology, while at the same time offering the broad perspective of how drugs affect the living organism, which is the foundation of our subject.

The programme is based on 18 two- or three- day focused conferences with a slate of top-level speakers throughout. In addition the programme offers world-class plenary lectures, as well as a range of workshops and sponsored symposia. There is a wide range of possibilities for involvement of young investigators and investigators from developing countries including poster sessions and free communications.

The programme thus provides a unique opportunity for the World's pharmacologists to meet for what is promised to be a scientifically excellent programme as well as the opportunity to savour the atmosphere of Copenhagen.

Kim Brøsen

Michael Mulvany
Secretary general


26–30 July 2010 eCheminfo Drug Discovery Workshop on Drug Discovery Design Methods & Applications

Medical Sciences Teaching Centre, Oxford University, Oxford, UK

These workshops are aimed to provide a set of stimulating workshops using latest advanced modelling techniques of relevance to chemists, life scientists and modellers working in drug discovery. Participants should return to their labs with new ideas, best practices and software experiences to maximise productivity in their own drug discovery research activities.

Workshop groups will study problems with hands-on examples using computational drug discovery methods and discuss issues highlighted by examples and Case Studies presented by instructors. A Case Study set with a focus on Kinases will be used to link all workshop activities throughout the week in which participants will work in small groups on their case study problems.

Software packages and an IT classroom will be used by instructors and participants to work through drug discovery and design problems. Participants may propose problems and issues to the faculty ahead of the workshop. Participants will also have ample opportunity to discuss their perspectives and criticisms of the methods studied and should take-away key nuggets of understanding from these intensive sessions.


16–17 September 2010 CNS Clinical Trials - Optimising development, management and recruitment for clinical trials in CNS

BSG House, London, UK

CNS is one of the largest and fastest growing therapeutic areas of the pharmaceutical market. The ageing of the baby-boom generation combined with new and emerging treatments for neurodegenerative disorders, including multiple sclerosis, Alzheimer\'s disease and Parkinson\'s disease, will lead to further expansion of the neurodegenerative therapies market. Increasing disease prevalence and a robust pipeline make that sector dynamic, and highly promising for pharmaceutical and biotechnology companies worldwide. (Source: Visiongain - World Neurodegenerative Diseases Market 2009 -2024)

At Visiongain’s CNS Clinical Trials conference you will examine the strategies offering the greatest potential for success in CNS drug development, and understand the specific challenges currently faced by developers in this market. In order to enhance productivity in this field, there has been an increased awareness of the need to align clinical and preclinical research to facilitate rapid development of new CNS drug therapies. Medical imaging is increasingly being used as a surrogate endpoint or biomarker of drug efficacy in all phases of CNS trials, enabling CNS developers to make more timely decisions.

As part of this 2-day event, leading industry and academic authorities will address how to balance risk and how attrition can be reduced to increase the chances of success in CNS clinical trials. Participants will look at overcoming some of the hurdles arising in designing, managing and recruiting for CNS clinical trials, and examine the tools and technologies to best enhance clinical development.

By attending this conference you will:

  • Examine novel approaches for assessing cognitive function
  • Explore the latest advances in neuroimaging
  • Develop effective methods for improved patient recruitment and retention
  • Understand statistical thinking for designing adaptive trials
  • Review Good Clinical Practice GCP guidelines
  • Address the regulatory challenges for CNS drug approval
  • Utilise biomarkers for Proof of Concept in CNS clinical trials
  • Improve trial outcomes through increased communication, ethical consent and patient care
  • Implement translational methods to bridge the gap between pre-clinical and clinical CNS trials
  • Be part of a major networking opportunity

Target Audience:

  • Pharmaceutical and biotech companies
  • Clinical research organisations
  • Regulatory agencies/ associations


20–21 September 2010 Personalized and Translational Medicine Summit USA

Radisson Hotel Boston, 200 Stuart Street, Boston, MA, 02116, United States

How to move from Blockbuster to Nichebuster Translational and personalized medicine have always been a part of biomedical and pharmaceutical research but we have now reached an area where they have become essential for staying competitive. What you’ll take away from this meeting: Discuss the roadmap of personalized medicine and how to make it work in your corporation. Discover the value and practical solutions for biomarkers in translational medicine. Find best ways for biomarker implementation in pre-clinical and clinical trails. What are the partnering options to make things happen? What is required from the business and regulatory side to make it work? Find successful organizational collaborations for the development of drug dependent biomarkers and make your drugs personal.


21–24 September 2010 Drug Analysis 2010

Antwerp, Belgium


  • Analysis of biomarkers
  • Analysis of biopharmaceuticals
  • Analysis of natural products
  • Analysis of pharmaceuticals
  • Analytical strategies for drug profiling
  • Analytical tools for genomics, proteomics, metabolomics, glycomics and lipidomics
  • Applications in pharmacokinetic and clinical studies
  • Bioanalysis
  • Chemometrics
  • Chiral separations
  • Detection of counterfeit drugs
  • Environmental analysis
  • Forensic and anti-doping analysis
  • Green analysis
  • High-throughput analysis
  • Hyphenated techniques
  • Innovation in separation science
  • Innovative spectrometry
  • Method validation and regulatory issues
  • Micro- and nanoscale analytical systems
  • Molecular recognition
  • Process analytical technology
  • Sample preparation


20 January 2011 Antibiotics 2011 - Where Now?

Burlington House, London, UK

As we are ever more acutely aware of the threats of antibiotic-resistant superbugs such as MRSA and C. difficile it has become more widely accepted that new drugs are needed which act upon new microbial targets. However, the cost to pharma of developing a new antibiotic - which could be rendered useless before the investment in its discovery has been recouped - has meant that many companies have no new drugs in the pipeline and more worryingly, have no active research in the area.

This timely, focused meeting builds upon the highly successful event in 2008 attended by over 170 delegates. It brings together international experts from big pharma, spin-out start ups, academics and national reference laboratories to provide an over-arching view of the field.

The conference will be split into two half-day sessions on the following themes:

- Clinical Problems
- Solutions and New Antibiotics

The conference aims to bring together scientists and clinicians from a range of sectors including the pharmaceutical industry, the NHS, academia, charities and funding councils. It is hoped that this meeting will be a focal point to discuss the critical issues that underpin the future of antibiotics; the clinical impact of hospital acquired infection; the development of new classes of antibacterials, the identification of novel targets and the solutions to the scientific and commercial obstacles to antibiotic research.


29–30 March 2011 4th Annual Drug Discovery World Asia 2011

Marina Bay Sands, Singapore

Drug Discovery World Asia 2011 is Asia's only event for scientists, biological R&D executives and principle investigators. This two-day conference boasts of a strategic content-driven programme and numerous networking sessions.

Drug Discovery World Asia 2011 focuses on the strategies in fast tracking life science research and drug discovery through innovative technologies and methodologies.

Drug Discovery World Asia 2011 will present to you successful case studies and expertise of over 30 leading companies. These companies have achieved efficient research and drug discovery systems through innovative technologies.


11–14 April 2011 11th annual World Vaccine Congress Washington 2011

Gaylord National Hotel and Convention Center, Washington DC, USA

In 2010 over 485+ delegates came to the 10th annual World Vaccine Congress Washington!

In 2011 you will have the opportunity to hear from North America’s leading governmental stakeholders, business leaders and scientific stakeholders as they continue to enhance the scientific and strategic innovation behind a burgeoning vaccine industry. These are the true visionaries of the vaccine industry revolution. A pioneer-studded faculty of over 135+ speakers including public health and regulatory bodies, large pharmaceuticals, biotechs, academia, NGOs, astute investors and respected visionaries who inspire industry imagination and achievement will greet the 2011 delegation.


8–9 June 2011 The 12th Annual Drug Discovery Leaders Summit 2011

Zürich, Switzerland

12th ANNUAL DRUG DISCOVERy Leaders Summit

The Pharmaceutical industry is experiencing declining productivity and success rates.  To stay competitive companies are both increasing collaborations and re-evaluating their drug discovery strategies in order to reduce attrition rates at later stages. Various research and decision making tools such as enabling technologies, biomarkers, and drug design are being enabled at different stages of the discovery process in order to revitalise efficiency and yield. Linking data produced during development stages back into discovery to produce translational and personlised medicine is also being utilised to bridge the gap between discovery and development.
The 12th Annual Drug Discovery Leaders Summit 2011 presented by Oxford Global Conferences provides a first class educational and networking opportunity for over 200 attendees to gain knowledge and insights into the entire Drug Discovery marketplace. Over 2 days, the comprehensive and scientific conference programme will feature key note addresses, case study presentations, panel and roundtable discussions of over 60 senior level industry speakers from leading pharmaceutical, biotechnology organisations as well as academia covering the following hot topics:

R&D STRATEGIES & BUSINESS MODELS– Challenges and strategies to enhance productivity in drug discovery such as open innovation, innovative collaboration models, stratification population strategies, addressing undruggable targets, early alliances & risk sharing portfolios and the assessment of drug discovery in a changing world.
– DNA Encoded libraries, fragment based design, outsourcing, knowledge based drug design, natural compounds and analysis into how biophysical methods support drug disocvery.
– Strategies to integrate biologics into classical R&D models, presentations focused on the expansion into peptides, stapled peptides, soluble T cell receptors and the resurgence in antisense drugs.
– Analysis of different technologies and their potential to benefit drug discovery such as antibodies, epigenetics, siRNA, RNAi, MicroRNA and constructing signalling pathways.
– Applications of Bioinformatics in discovery, focusing on uses of systems biology to find new targets, making models to make data more relevant to man and knowledge management tools.
– Improving value from HTS, potential of novel screening technologies, label free, disruptive technologies, potential of pluripotent stems cells Plus IMI Open Pharmacological Space Project.


1–5 July 2011 Polymers in Medicine 2012

Prague, Czech Republic

The 76th Prague Meetings on Macromolecules: Polymers in Medicine will focus on the latest innovative development in drug delivery systems. Meeting brings together multi-disciplinary researchers from both academia and industry in the areas of pharmaceutics, polymer and materials science, imaging, cell and molecular biology, genetic, and medicine.

Prague Meetings on Macromolecules: Polymers in Medicine 2012 will be dedicated to Professor Karel Ulbrich (Prague, Czech Republic), a leading scientist in the field of polymer drug delivery in the Czech Republic. The polymer conjugates of doxorubicin based on N-(2-hydroxypropyl)metharylamide copolymers, known a PK1 and PK2, developed in cooperation of  Institute of Macromolecular Chemistry and University of Keele were the first polymer drug conjugates entering the clinical trial. Prof. Ulbrich as scientist, teacher, academic visionary and entrepreneur tirelessly worked for internationalization of the field of drug delivery systems.


6–8 July 2011 RICT 2011 - Drug Discovery and Selection

Lyon, France

The scientific programme, approved by the industrial and academic members of the scientific committee, is focused on drug discovery and selection. Various major and fascinating topics, going from biological, bio-physical and computing tools, through screening and organic synthesis to the discovery of new treatments, are proposed. The programme will include over 20 plenary lectures by internationally well-known scientists.

The scientific committee ensures the high quality and diversity of the scientific programme together with the accessibility of the meeting to MSc and PhD students. For the latter, an advantageous registration fee will be proposed. Moreover, a special career session will be organised with industrial and academic participants.

During the meeting the traditional prizes (P. Ehrlich Lecture Award and C. Mentzer Prize) of the ‘Société de Chimie Thérapeutique’ will be awarded to researchers or research teams for their outstanding contributions to medicinal chemistry. In addition, a poster session will provide the opportunity for all participants to present their current results. A “best poster” prize will also be conferred.
The Lyon metropolitan area, the largest in the Rhône-Alpes region, lies in a strategic location in the natural plain of the Rhone Valley. It is surrounded by the Beaujolais country in the north, the Monts du Lyonnais in the west, and the plains of the Dombes and Isère in the east and north.

Lyon has a long cultural influence on France and the world. The city is known for its historical and architectural landmarks and is a UNESCO World Heritage Site.


- ADME Tox
- Case Studies
- From in Silico Selection to Development
- From Screening to Development
- Hit to Lead
- New Useful Tools in Organic Chemistry
- Other Innovative Approaches
- Target Discovery and Validation


31 July–4 August 2011 23rd International Congress on Heterocyclic Chemistry (ICHC-23) 2011

SECC, Glasgow, Scotland

On behalf of the Organising Committee of the 23rd International Congress on Heterocyclic Chemistry (ICHC-23), the International Society of Heterocyclic Chemistry (ISHC), and the Universities of Strathclyde and Glasgow, I extend a warm welcome to you to take part in ICHC-23 in Glasgow in 2011. The Congress will be held at the Scottish Exhibition and Conference Centre (SECC) on the banks of the river Clyde in Glasgow, Scotland between 31 July and 4 August 2011.

In conjunction with our International Advisory Committee we plan to have an exciting range of cutting edge heterocyclic chemistry on offer to reflect recent advances in a truly international coverage. At this stage we envisage five main themes of heterocyclic chemistry: synthetic methodology, natural product and complex molecule synthesis, materials, medicinal chemistry and nanochemistry.


9–11 August 2011 BIT's 2nd Annual International Conference of Medichem-2011

Beijing, China

Theme: Master Drug Discovery Chemistry


- Biosciences and Chemical Biology & Medicinal Chemistry
- Novel Technologies in Medicinal Chemistry
- Rational Target-based Drug Design and Synthesis
- Lead Optimization toward Drug Candidates
- Biotherapeutic and Natural Product Medicinal Chemistry
- Drug Synthesis and Production
- Medichem R & D Outsourcing Alliance Trend


4–7 September 2011 Sixth Cambridge Symposium on Nucleic Acids Chemistry and Biology

Cambridge, UK

An international, residential meeting at historic Queens' College in the heart of Cambridge with on-site accommodation and excellent auditorium, poster and exhibition areas. This is the 6th in a popular conference series going back to 1981 that brings together nucleic acids scientists across a broad area but with particular emphasis on chemistry and biochemistry.


18–22 September 2011 2nd World Conference on Physico Chemical Methods in Drug Discovery and Development

Zadar, Croatia

Physical chemistry – meeting the challenges along the path to improved formulation and new drug

As a continuation of the successful 1st PCMDDD, this Conference aims to further strengthen the communication and cooperation among scientists and experts working in academic institutions or industry. The intention of the Organizing committee is to provide an opportunity for the organizers, sponsors and world scientific community closely related to pharmaceutical research, to come together and present their original work, share experiences and problems in warm and stimulating  atmosphere.

More specifically, the aim of the Conference is to address the most advanced directions and new achievements in physical chemistry methods applied to the research processes in drug discovery and pharmaceutical development. Topics covered in the conference program include separation techniques, methods of spectroscopy and microscopy, thermal analysis and physico-chemical profiling including dissolution and permeability. However, this list is by no means exhaustive.

A diverse, well-balanced scientific programme is planned. The participants are encouraged to submit their abstracts either for Oral presentation or Poster exhibition. Pleanary lectures will be delivered by prominent and highly respected professionals selected for their past credentials and their distinctive vision of the future.

In addition, a few courses and workshops will be organized for those willing to acquire a comprehensive overview of the specific field of application in particular physico-chemical technique.

We are looking forward to welcoming you in Zadar.


20–22 September 2011 MipTec - The Leading European Event for Drug Discovery

Congress Centre, Basel, Switzerland

MipTec is the premier European conference and exhibition encompassing innovative approaches to high quality science and technology for efficient drug discovery.

The mission of MipTec is to bring together scientists from all disciplines involved in drug discovery within pharmaceutical and biotech companies, academic labs and technology providers in an atmosphere, where ideas and experiences are shared and discussed. This atmosphere is created through a scientific program covering key topics and the latest breakthroughs in the diverse fields that make up drug discovery.


3–5 November 2011 BIT's 2nd Annual World Congress of Nanomedicine - 2011

Shenzhen, China

The world nanomedicine market is suggested to surpass $160 Billion by the year 2015. This huge market demand has provided unprecedented space for innovators and industrial developmers to push the limit of Nanotechnology fully applied for diversified medical fields as many as possible. This congress including six parallel scientific symposia will energize your great passions to showcase the most recently breaking research, discovery and industrial milestones in Nanomedicinal R & D and Business development. As a co-current meeting to BIT’s 9th Drug Discovery Congress, i.e. IDDST-2011, and the 1st Drug Delivery System Congress, this year Nanomedicine congress will offer you huge opportunities for catching the fast growing market trend and collaborative business potential through the dynamic scientific and social activities along the events with our colleagues.


29 November–1 December 2011 7th annual European Antibody Congress 2011

Crowne Plaza, Geneva, Switzerland

The European Antibody Congress is the world’s leading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Showcasing major antibody structural improvements, global trends, recent intra-market authorisation and clinical progress, this event sees unrivalled industry participation. Hear, learn, debate and act on the most critical scientific and business opportunities in the antibody sector.

The 250+ audience is primarily made up of Pharmaceutical companies and Biotechs. Supporting their projects, Technology Providers, CROs, CMOs and Researchers also attend. Over 50 leading scientists from Big Pharma and specialised biotech companies will share their expertise and groundbreaking conclusions throughout three jampacked days.

Speakers include: Merrimack Pharmaceuticals Inc, Schering Pharma AG, Lonza Custom Manufacturing, Wilex AG, Eli Lilly and Company, GenMab, Morphotek Inc, University of Zurich, Tufts Centre for the Study of Drug Development and mAbs journal, Ablynx,  Kenta Biotech AG, Pfizer  Global Biologics, CBER/FDA, Protagen AG, MedImmune, Roche Glycart AG, Icosagen Cell Factory OU, Johnson & Johnson, Fresenius Kabi, Bayer, Genentech, Inc, Centre d'Immunology and Vaccinex.


21–23 February 2012 BAMP 2012: International Scientific Conference on Bacteriocins and Antimicrobial Peptides

Kosice, Slovakia

At BAMP2012 leading scientists from industry and academia will present and discuss current advances in the research of bacteriocins and antimicrobial peptides. Key themes will be isolation, characterization, mechanism-of-action, food, clinical and veterinary applications of novel or already characterized bacteriocins produced by lactic or non-lactic acid bacteria.


11–14 March 2012 Arden Conference Nanoscience in Pharmaceuticals: Translating Fundamental Understanding to Practical Application in Drug and Device Development

West Point, NY, USA

Particular emphasis will be placed on establishing and distinguishing among what is being accomplished now based on marketed products and what is feasible based on drugs and devices and combinations thereof in clinical and preclinical development. Emerging nanotherapeutics and nanodevices based on early preclinical data will be included in the discussion.


12–13 March 2012 BICB 2012: 2nd Annual International Conference on BioInformatics and Computational Biology

Bangkok, Thailand

The aim of this BICB conference is to provide a platform for communication among top notch researchers, practitioners, and students from around the world in different fields of computer science, computer engineering, applied computing and computational biology to discuss the latest advances in the development of computing techniques and their application to life sciences.

The conference will feature original research in all areas of bio-informatics and computational biology, and covering the entire spectrum of underlying computational techniques in topics such as genome analysis sequence analysis, phylogenetics, analysis of high-throughput biological data, systems genetics, population analysis, as well as structural bioinformatics.


12–14 March 2012 Therapeutic Applications of Computational Biology and Chemistry (TACBAC) 2012

Hinxton, Cambridge, UK

This conference will bring together leading researchers investigating computational chemistry and biology techniques as applied to advancing our ability to predict, diagnose and modulate human disease. This broad and multidisciplinary meeting will explore the major challenges in drug discovery and development where innovation in computational approaches and tools can really make a significant and tangible contribution towards novel treatments.  You should attend this conference if you are a researcher interested in drug discovery, or developing or using computational approaches to the development of therapeutics, or if you are a key decision maker in a pharmaceutical or biotechnology company.


19–22 March 2012 8th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

Istanbul, Turkey

The development of medicines is posing not only major challenges to research, development and manufacturing but also to all aspects related to the safety of products from quality control to regulatory affairs. APGI (French “Association de Pharmacie Galénique Industrielle”), APV (German “International Association for Pharmaceutical Technology”) and A.D.R.I.T.E.L.F. (Italian “Associazione Docenti Ricercatori Italiani di Tecnologie e Legislazione Farmaceutiche”) invite you to discuss the risks, opportunities and challenges of this development.


19–21 March 2012 Continuous Flow Technology in Industry

York, UK

This international symposium follows on from the RSC Symposium on Continuous Flow Technology held at ChemspecEurope 2011 in Geneva.

The production of speciality chemicals is still heavily reliant on batch processes, particularly in the pharmaceutical sector, and this symposium will highlight recent developments focussed on the growth of continuous processes in the fine chemicals and pharma industries.

All the speakers are experts in their field and the presentations will be grouped into two sessions on Chemistry with Flow, two sessions on Equipping for Flow, and the final day will be devoted to three sessions on Processing with Flow. Specialised techniques, low temperature work, use of microwaves, hazardous chemistry etc., scale up, process optimisation, and production will be featured.


22 March 2012 The Joint Pharmaceutical Analysis Group: Advances in pharmaceutical analysis

London, UK

This symposium will be of interest to analytical, pharmaceutical and regulatory scientists involved in pharmaceutical research, development and manufacturing. It will be of particular interest to scientists and managers engaged in analytical development or quality control, where advances in analytical technologies and practices can enhance productivity, problem-solving or quality-by-design capabilities.


21–24 April 2012 RECOMB 2012, the 16th Annual International Conference on Research in Computational Molecular Biology

Barcelona, Spain

RECOMB is a well-established scientific conference bridging the computational, mathematical, and biological sciences. The conference features keynote talks by preeminent scientists in the life sciences, together with presentations of refereed research papers in computational biology.


9–11 May 2012 ISOPP XIII: the 13th International Symposium on Oncology Pharmacy Practice

Melbourne, Australia

ISOPP symposia are prestigious biennial educational events that bring together oncology pharmacy practitioners, and other interested personnel, from all over the world.

The program for ISOPP XIII is designed to stimulate debate and discussion, increasing delegates’ knowledge to both improve an individual’s cancer care journey and the safe working conditions of people preparing cytotoxic treatments. The scientific program will include sessions on recent advances in oncology/haematology therapeutics, new investigational drugs, safety issues, and innovative concepts, trends and technologies that will improve patient care. An important part of any ISOPP Symposium is the opportunity for delegates to network and exchange information during the breaks and at the social functions and this symposium will be no different.


9–11 June 2012 16th International Congress PHYTOPHARM 2012

St-Petersburg, Russia

The comprehensive scientific program covers many important and current aspects of the pharmaceutical sciences and pharmaceutical industry. Invited lectures will be given by famous lecturers and leading scientists from Universities, industry and regulatory authorities.


12–15 June 2012 ISACS7: Challenges in Organic Chemistry and Chemical Biology

Edinburgh, UK

Challenges in Organic Chemistry and Chemical Biology will be the first event in the International Symposia on Advancing the Chemical Sciences (ISACS) series in 2012.

Organic chemistry is a core area of chemistry. Fundamental research in synthesis is leading to innovation through process improvement and invention of new types of transformations. Novel procedures can create the new substances which society needs to develop.


12–14 June 2012 IPC2012: International Scientific Conference on Probiotics and Prebiotics

Kosice, Slovakia

IPC2012 is the oncoming event of the successful conference series focusing on probiotics in 2000, 2004, 2008, 2010 and 2011. The scientific programme will focus on current advances in the research, production and use of probiotics and prebiotics with particular focus on their role in maintaining health and preventing diseases.

The conference's goal is to provide a scientific forum for all stakeholders of probiotics and prebiotics and enable the interactive exchange of state-of-the-art knowledge. The conference will focus on evidence-based benefits proven in clinical trials and scientific experiments.


9–12 July 2012 Epigenetic Therapies and Biomarkers

Poitiers, France

Epigenetics focuses on environmental, nutritional and (bio)chemical factors influencing gene expression, in the absence of changes in DNA sequence. This training school is proposed to young and confirmed scientists wanting to increase their knowledge in this field. For scientists already involved in epigenetics, this is an opportunity to acquire knowledge on other scientific strategies developed to unravel the functional impact of epigenetic mechanisms. The workshop will include presentations on: design of inhibitors to epigenetic targets, methods for measuring epigenetic activities, epigenetic protein interactions and functional impact of epigenetic modifications.


12–17 August 2012 Translational Drug Carriers: From Design and Understanding Mechanism of Action to Clinical Use

Waterville Valley, NH, USA

The 2012 Gordon Conference on Drug Carriers in Medicine and Biology is a well established forum with three decades of history, focused on the principles and means for improvement of pharmacotherapy and diagnostics of human maladies employing advanced drug delivery systems. It will bring together an exciting multi-disciplinary group of prominent academic and pharmaceutical/biotechnology researchers working to develop and implement such new medical and experimental interventions. The conference will feature integrated sessions that bring together cutting-edge advances in intracellular drug delivery, biotherapeutics including protein and nucleic acid drugs, nanotechnology and nanomedicine, polymer- lipid- and cell-based carriers, carriers for targeted therapeutics, vascular and CNS targeting, vaccine delivery. Themes to be explored include molecular and cellular targets for drug delivery and action, siRNA and other nucleic acid therapeutic and delivery platforms, drug transport across biological and cellular barriers, defining biological factors modulating drug delivery and effects and enabling experimental and translational approaches for pre-clinical and clinical development. The conference provides a dynamic, diverse and collegial environment for collaboratively identifying current barriers and interdisciplinary solutions to pressing medical needs, and facilitates the informal mixing of an international group of researchers, junior and senior scientists, as well as academic, industrial and regulatory viewpoints. The conference is also noted for its lively poster sessions and selected short talks from poster presenters. The wonderful resort setting at the Waterville Valley Resort will provide many opportunities for informal discussions and outdoor recreation activities as part of the conference registration. We recommend early application to the Drug Carriers in Medicine and Biology GRC as attendance is limited, and welcome applications from junior scientists to attend and present their research findings. A number of travel awards will be made based on submitted poster abstracts.


4–8 September 2012 DrugDesign2012: Structure-Based Drug Design

Oxford, UK

DrugDesign 2012 - Oxford’s first drug design conference - will address the latest developments in computational and experimental approaches to ligand- and structure-based drug design. This conference is aimed at bringing together scientists from academia and industry to stimulate and step up the development of cutting-edge in silico and experimental drug design approaches. The conference invites podium and poster proposals in the following general areas of drug design:-

Molecular modelling and simulation Novel drugable targets: Identification and selection Fragment binding and selectivity Structure-based inhibitor design Ligand design and identification Target-ligand interaction (including proteins and nucleic acids) In silico and experimental screening technologies.


5–7 September 2012 International Conference on Central Nervous System - Drug Effects & Novel Drug Development

Philadelphia, PA, USA

Central Nervous System-2012 is a remarkable event which brings together all the leading universities, Central Nervous System researchers as well as institutions, making the conference a perfect platform to share experiences, foster collaborations across industry and academia and also evaluate emerging technologies across the globe.
International Conference on Central Nervous System - Drugs Effects, Novel Drug Development will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Research of Central Nervous System across the world. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies.


5–8 September 2012 3rd International Symposium on Biological Application of Dendrimers

Toledo, Spain

Dendrimers are monodisperse polymeric material with branched architecture. Over the last few decades dendrimers have developed into one on the most promising research area of the modern natural sciences. Dendrimers have enormous potential for medical applications. The first Biodendrimer symposium was organised by Dra. Bryszewka and Dra. Klajnert in Lodz, Poland (2008); followed by Dra. Peng and Dr. Majoral in Porquerolles Island, France (2010). The Biodendrimer symposium, which will be held in Toledo (Spain) from 5th to 7th of September 2012, will be co-organised together with the second COST conference on “Biological Applications of Dendrimers” (Action COST TD-0802) whose Management Committee meeting will be held in the same venue on 8th of September.

The aim of this Biennial International Symposium on dendrimers is to bring together the research and industrial groups working on biological and medical applications of dendrimers both at the European and international levels, to present and discuss the recent developments in this scientific field and to promote fruitful collaborations among the different groups. The symposium is organised around a strong scientific programme based on plenary lectures and oral communications with sufficient breaks and social gatherings to provide for collaborative networking opportunities, including a welcome reception, poster sessions, coffee breaks, and poster prizes.


10–11 September 2012 Biomarkers in Drug Discovery & Developmentwith

Berlin, Germany

With the increase of biomarkers application since the beginning of the 21st century, we are now not only seeing a great potential in improving the efficiency and safety of drug development, but we are also coming across some barriers which may slow these processes down.
To answer the challenges connected with utilization of biomarkers, we bring together the pharmaceutical minds along with representatives from academia, research institutions and non-profit organizations.
Two focused conference days offer case studies exploiting the best practices inaccelerating the identification of biomarkers, cutting the costs of attrition of compounds, reducing the size, cost and duration of clinical trials as well as the possibility of adverse events.


20–22 September 2012 CESPT 2012: 9th Central European Symposium on Pharmaceutical Technology

Dubrovnik, Croatia

The Central European Symposium on Pharmaceutical Technology is one of Europe’s finest pharmaceutical events. In 2012 the CESPT Symposium will once again provide an exclusive and personal forum by bringing together dedicated members and foster intellectual exchange on cutting-edge topics in pharmaceutical technology.


24–27 September 2012 MipTec - The Leading European Event for Drug Discovery

Basel, Switzerland

Welcome to the 2012 MipTec - the premier European Drug Discovery Event!

This year, MipTec will again take place at the Congress Center Basel, providing a focal point for the Scientific Sessions, User Group Meetings, and, of course, the vendor show.

The meeting will continue its focus on drug discovery, and also add a new scientific session on Synthetic Biology. We are also pleased that MipTec will continue to host User Group Meetings, on both new and returning topics.

Because our participants are committed to staying at the frontier of drug discovery knowledge and application, this year we have also arranged the session to enable attendance at both the MipTec chemistry session, and the EMBL Chemical Biology Meeting.

MipTec 2012 will continue the structure of previous meetings, with free registration (at www.miptec.com), so please attend

MipTec 2012, Basel, Switzerland, 24 - 27 September 2012


11–12 October 2012 Delivery Strategies for Biologics - New Technologies for the Next Generation of Biotherapeutic Drugs Products

Providence, RI, USA

Delivery Strategies blends practical solutions related to the development of high dose drug products and drug/device combinations with forward looking information on novel delivery approaches for biotherapeutics.

Conference Sessions Explore the Emerging Science Behind Targeted Biologics Delivery and Next-Generation Routes of Administration:

  • Delivery Strategies for High Viscosity and High Concentration Drug Products
  • Co-Development Strategies for Biologic-Device Product Combinations
  • Localized and Targeted Delivery of Biologics
  • Next Generation Routes of Administration for Biologics


22–24 October 2012 Related Events PDA's 7th Annual Global Conference on Pharmaceutical Microbiology Course Series Downloads Registration Form Justification Letter Exhibitor Toolkit Exhibitors List Exhibitor Contract Floor Plan Company Prodcut Form Exhibitor Badge Form Spons

Bethesda, MD, USA

PDA's 7th Annual Global Conference on Pharmaceutical Microbiology will bring together all levels of industry professionals to network and benefit from a program that reveals the essential science of microbiology and seeks to solve the problems that our industry faces on a daily basis. The comprehensive program agenda will include presentations from regulatory and industry representatives from around the world who will share recent case studies, current and future trends in the field of pharmaceutical microbiology.


29–30 October 2012 Nanomedicine & Drug Delivery Symposium - NanoDD's 12

Atlantic City, NJ, USA

Program Topic: Nanocarriers of Different Composition, Architecture, Size and Charge for Treatment and Imaging


29–31 October 2012 International Conference and Exhibition on Computer Aided Drug Design & QSAR

Chicago-North Shore, IL, USA

International Conference and Exhibition on Computer Aided Drug Design & QSAR is a remarkable event which brings together a unique and International mix of large and medium biotech and diagnostics companies, leading universities and drug designing institutions making the conference a perfect platform to share experience, foster collaborations across industry and academia and evaluate emerging technologies across the globe.

The International Conference and Exhibition on Computer Aided Drug Design & QSAR will schedule and coordinate all meetings with our Editorial Board Members and other experts in the Computational studies & Drug Design field across the World. The Scientific Program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies in Computer Aided Drug Design & QSAR.


21–23 November 2012 The II International Conference on Antimicrobial Research (ICAR2012)

Lisbon, Portugal

The II International Conference on Antimicrobial Research (ICAR2012) will be a forum for the presentation, exchange and dissemination of information and experiences on anti-microbe strategies, in biotic or abiotic environments, in planktonic or adhered states, in biologically specific or unespecific ways, in vitro or in vivo, in a general context marked by the threat posed by the increasing antimicrobial resistance of pathogenic microorganisms. “Anti” is here taken in a wide sense as “against cell cycle, adhesion, or communication”, when harmful for the human health, industry or economy (infectious diseases, chemotherapy, food, biomedicine, agriculture, livestock, biotechnology, water systems...). It will cover topics on antimicrobial resistance, (early) microbial and resistance detection, enhancement of innate defences against pathogens, as well as methods & techniques.



San Francisco, CA, USA

The Drug Discovery for Neurodegeneration conference advances drug discovery for neurodegenerative diseases by educating scientists on the process of translating basic research into novel therapies.


9–11 April 2013 Drug Discovery Informatics

Boston, MA, USA

Track 9 will showcase collaborations that address the challenge of information integration and standardization for drug discovery, recent researches on pharmacogenomics through the integration of clinical genomics information system with electronic medical records, in order to advance human health through genomics research. Novel informatics approaches in drug discovery, in areas such as tissue-specific mutations and epigenetics will also be examined.


15 April 2013 Antiviral Drug Discovery

San Diego, CA, USA

This one-day symposium will bring together medicinal chemists who discover and develop new antiviral therapies. With the world becoming a smaller place, viral infections once contained to specific areas are now more wide-spread, increasing the need for novel therapies to combat once-rare viral infections. Thus, in addition to following the promising progress of new all-oral combination therapies to combat viral drug resistance for HIV and HCV, the meeting will also focus on treatments for human-targeted viruses that represent emerging unmet medical needs.


15 April 2013 Property-Based Drug Design

San Diego, CA, USA

The optimization of physical properties of a compound is fundamental to the drug discovery process, mainly due to their influence on absorption and distribution in vivo. They provide insight into the in vivo transport processes and knowing the properties will help with choosing the optimal compounds for the task.  It saves costs and time, when compounds are being properly analyzed in the design stage before they are moving into development, as it is important to consider questions such as  how hydrophobicity will affect the solubility of a drug down the line or how the charge of the compound interacts with the absorption by a transport mechanism. Also, the use of predictive models is important, but again, without consideration of the actual physical chemical property of the new compound, the analyses will be based on a different set of data. This one-day symposium will discuss what it takes to create selective and efficacious compounds and to understand the biological data by analyzing the physicochemical properties early on.


16–17 April 2013 Constrained Peptides and Macrocyclics Drug Discovery

San Diego, CA, USA

Peptide therapeutics are making a come-back due to chemical advances that have created new sorts of peptide-based structures that not only combine the best of both, small molecule and antibody drug candidates, but also have unique advantages. Like small molecule compounds, these new peptide derivatives are small enough (under 5 kilodaltons) to be developed into oral therapeutics, but they have the advantage of being large enough to disrupt protein-protein interactions, making them more useful against intracellular targets. This new class of peptides also has the specificity of larger proteins, such as monoclonal antibodies, but without the stability issues. This day and a half meeting will explore the chemistry and drug development advances behind this promising middle space of compounds that are slightly larger than 'small molecules' but smaller than 'biologics'.


16–17 April 2013 Anti-Inflammatories

San Diego, CA, USA

CHI's Anti-Inflammatories: Small Molecule Approaches continues to be the ONLY meeting in the inflammation field that focuses on the discovery and development of oral or small-molecule based drug candidates. Anti-body based therapies, while effective and safe, are costly and harder to administer than an oral pill.  With the JAK inhibitors progressing in the clinic and one recently approved by the FDA, the promise of a new anti-inflammatory as good as the non-steroidal anti-inflammatories (NSAIDS) but without the gastric side effects, is tangible. Other oral anti-inflammatory drug candidates are on the horizon as well. This year's meeting will provide an update and highlight the medicinal chemistry optimizations that are allowing kinase inhibitor candidates to advance in clinical trials. Non-kinase targets will be a focus as well.


17–18 April 2013 GPCR-Based Drug Design

San Diego, CA, USA

The past few years have witnessed an increased pace of reports on different G protein coupled receptors or GPCR-ligand pairs whose crystal structures have been elucidated. How can this new structural information be harnessed for drug development against one of the most medically important but difficult to work with class of targets? This inaugural day and a half meeting will bring together computational, crystallographic modelers and medicinal chemists to learn and share how these advances are affecting the optimization of compounds that target GPCRs.


17–18 April 2013 Protein-Protein Interactions

San Diego, CA, USA

Cambridge Healthtech Institute's conference on Protein-Protein Interactions has established itself as a successful and well attended event year after year. Now in its sixth year, this conference is addressing current challenges in PPI such as interaction with binding sites, modulation of PPI, predicting PPI modes and what can be done to target PPI successfully.


3–6 June 2013 Drug Discovery & Therapy World Congress 2013

Boston, MA, USA

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss and learn about important international breakthrough developments in drug discovery and on new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine. A similar series of conferences have been held by the organizers in the UAE over the last several years. These events have been highly successful and many top international scientists, including over 22 Nobel Laureates, have presented their work.


3–5 July 2013 RICT 2013

Nice, France

The scientific committee ensures the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee will be proposed. Moreover, a special career session will be organised with industrial and academic participants.


31 August–5 September 2013 World Congress of Pharmacy and Pharmaceutical Sciences 2013

Dublin, Ireland

Every year, FIP organises the World Congress of Pharmacy and Pharmaceutical Sciences, where thousands of pharmacists meet, learn, share and exchange views. Lectures, plenary sessions, poster exhibitions and section programmes, together with Council meetings and the Leadership Conference make this event the premier international event in pharmacy each year.

The annual Congress also serves the Young Pharmacists Group with specially planned sessions and workshops focussed on current issues facing this unique segment of the profession.


15–20 September 2013 MaNaPro - the 14th International Symposium on Marine Natural Products and the 8th European Congress on Marine Natural Products 2013

La Toja Island, Galicia, Spain

The 14th International Symposium on Marine Natural Products and the 8th European Congress on Marine Natural Products 2013 is going to be held on the Island of La Toja, Galicia, Spain between the 15th and 20th of September, 2013 and is organised by PharmaMar.

You are invited to present your recent work and ideas covering all areas related to marine natural products research. Abstracts and/or posters should be submitted no later than the 31th of May, 2013.


17–19 September 2013 4th RSC/SCI Symposium on GPCRs in Medicinal Chemistry

Windlesham Surrey, UK

G-protein-coupled receptors (GPCRs) play a crucial role in transmitting chemical signals across cell membranes and converting them into cellular responses. As such, they are involved in many diseases and continue to represent the target of a large proportion of all modern medicinal drugs. Building on the success of the previous three meetings, the latest meeting in this series was supported by Lilly UK.


24–26 September 2013 MipTec 2013

Basel, Switzerland

The mission of MipTec is to bring together scientists from all disciplines involved in drug discovery within pharmaceutical and biotech companies, academic labs and technology providers in an atmosphere, where ideas and experiences are shared and discussed. This atmosphere is created through a scientific program covering key topics and the latest breakthroughs in the diverse fields that make up drug discovery.


13–16 April 2014 5th FIP Pharmaceutical Sciences World Congress Melbourne, Australia 13-16 April 2014

Melbourne, Australia

Join leading pharmaceutical scientists from around the world to discuss cutting edge research and up-and-coming developments under the theme ‘Pharmaceutical Sciences beyond 2020 – The rise of a new era in healthcare’.

A very exciting venue, where the leading pharmaceutical scientists from across the globe will meet to discuss the future:

Where will the pharmaceutical sciences be beyond 2020? What should be our f0cus? What will be the break-throughs and the pitfalls? How can we meet the biggest challenges?


–  Network with key leaders in pharmaceutical sciences from all over the world

–  Learn from leading experts on what will happen beyond 2020

–  Enjoy hearing high level speakers recount their latest research findings in plenaries, keynotes, workshops, debates, roundtables and unique regional showcases

–  Attend the parallel APSA (Australasian Pharmaceutical Science Association) and DDA (Drug Delivery Australia) congresses

–  Enjoy beautiful Melbourne, known as ‘the world’s most livable city’


21–22 May 2014 11th Mastering Medicinal Chemistry

Boston, MA, USA

Senior executives and industry thought leaders from Pfizer, Roche, Sanofi, GlaxoSmithKline, Bristol-Myers Squibb, AbbVie, AstraZeneca and many more will participate in this year’s program with inspiring discussions on the future role of medicinal chemistry and its contribution to improved drug discovery rates.


16–19 June 2014 Drug Discovery & Therapy World Congress 2014

Boston, MA, USA

This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics.


13–18 July 2014 The 17th World Congress of Basic and Clinical Pharmacology (WCP2014)

Cape Town, South Africa

The IUPHAR world congresses foster basic and clinical pharmacological sciences. As it is the first time this event will be held on the African continent, the organising committee is excited to bring a uniquely African experience to this global event. We have no doubt that the opportunity to connect with world leaders in pharmacology, industry and thought leaders in a memorable location defines WCP2014 as an event of scientific excellence not to be missed.


10–14 August 2014 Biological and Pharmaceutical Complex Fluids II: Novel Trends in Characterizing Interactions, Microstructure and Rheology

Durham, North Carolina, USA

This meeting, the second in this ECI series, will focus on bringing together a wide range of multi-disciplinary groups from academia and industry with a view to discussing key challenges, recent developments, and future trends in characterization of biological complex fluids with a specific focus on the Biotherapeutics & Foods industrial sectors.


31 August–4 September 2014 62nd International Congress and Annual Meeting of the Society for Medicinal Plant and Natural Product Research

Guimaraes, Portugal

The Society for Medicinal Plant and Natural Product Research (GA) invites all scientists from academia and industry dealing with natural products, medicinal plants and phytotherapy, to this congress. GA2014 is a forum for the presentation and discussion of the latest research in the fields of phytochemistry, analytics, pharmacology and clinical applications. The conference will provide a platform for networking between academia and industry.


31 August–4 September 2014 20th EuroQSAR

St. Petersburg, Russia

The EuroQSAR Symposia have been taking place since 1973 and constitute the major scientific events in the field of computer-aided drug design & discovery, with further applications in agricultural and environmental sciences. The 2014 symposium will not only follow the tradition of previous events in presenting latest trends in QSAR and molecular modeling, it will also explore new grounds, such as integrated approaches and open innovation strategies in drug discovery.

The 20th EuroQSAR symposium, entitled Understanding Chemical-Biological Interactions, will include 9 plenary lectures and 28 oral communications to be selected from the submitted abstracts .

The Scientific Programme will be completed by Company Workshops, a Poster Session, a Commercial Exhibition as well as an impressive Social Programme around Saint-Petersburg, capital of culture of Russia and a UNESCO landmark.

More info is available on www.euroqsar2014.org


14–18 September 2014 Particulate Processes in the Pharmaceutical Industry IV

Potsdam, Germany

This conference, by bringing together researchers from industry and academia, will be showcasing and demonstrating how the latest R&D in particulate processing can be applied to pharmaceutical industrial design and optimisation as well as how they can cater to emerging regulatory needs. A combination of oral presentations, poster sessions, and workshops will demonstrate the existing expertise and establish future research needs.


18–21 November 2014 26th EORTC-NCI-AACR Symposium on 'Molecular Targets and Cancer Therapeutics

Barcelona, Spain

Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2014 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology.


29–30 January 2015 Novel Immunotherapeutics Summit 2015

San Diego, CA, USA

GTCbio’s Novel Immunotherapeutics Summit will take place on January 29-30 in San Diego, CA. The summit includes three parallel conferences:13th Cytokines & Inflammation, 7th Immunotherapeutics & Immunomonitoring, and 3rd Immunogenicity and Immunotoxicity.


26–27 February 2015 Catalyses in Drug Discovery Summit

San Diego, CA, USA

GTCbio’s Catalyses in Drug Discovery Summit will take place on February 26-27 in San Diego, CA. The summit includes three parallel conferences: 5th Ubiquitin Research and Drug Discovery, Enzymes in Drug Discovery, and Protease Inhibitors in Drug Discovery.


18–20 March 2015 Biomarker Summit 2015

San Diego, CA, USA

GTCbio’s Biomarker Summit 2015 will take place on March 18-20 in San Diego, CA. The summit includes three parallel conferences: 8th Oncology Biomarkers, 4th Neurological Biomarkers, and 4th Inflammatory & Immunological Biomarkers.

Biomarker Summit 2015

19–20 March 2015 7th Ocular Diseases Drug Discovery

San Diego, CA, USA

GTCbio’s 7th Ocular Diseases Drug Discovery will take place on March 19-20 in San Diego, CA.The conference will discuss combating and curing age-related macular degeneration (AMD), diabetic retinopathy, glaucoma, diabetic macular edema (DME), and other ocular diseases.


27–29 April 2015 Diabetes Summit 2015

Boston, MA, USA

GTCbio’s Diabetes Summit 2015 will take place on April 27-29 in Boston, MA. The summit includes two parallel conferences: 5th Diabetes Partnering & Deal-Making, and 8th Diabetes Drug Discovery & Development.


27–29 April 2015 Stem Cell Summit 2015

Boston, MA, USA

GTCbio’s Stem Cell Summit 2015 will take place on April 27-29 in Boston, MA. The summit includes two parallel conferences, 12th Stem Cell Research & Regenerative Medicine, and 4th Stem Cell Product Development & Commercialization.


21–22 May 2015 The Pan-Omics Summit

Boston, MA, USA

GTCbio’s Pan-Omics Summit will take place on May 21-22 in Boston, MA. The summit is comprised of 4 parallel conferences: 5th Next Generation Sequencing, 2nd Metabolomics - Advances & Applications in Human Disease, Epigenomics & Novel Therapeutic Targets, and Functional Genomics.


26–31 May 2015 21st International Symposium on Radiopharmaceutical Sciences

Columbia, Missouri, USA

The main research topics should include the whole range of radiopharmaceutical sciences and consist of, but not limited to:

  • Radioisotope production
  • Labeling methods and radiosynthesis
  • Automation
  • Radiopharmaceutical development for
    • Receptors
    • Enzymes
    • Transporters
    • Other biological systems
  • (GMP) production and QC
  • Radiopharmacology


4–5 June 2015 29. Journees Franco-Belges de Pharmacochimie

Spa, Belgium

The “Journée Franco-Belge de Pharmacochimie” is a recognized annual meeting on Medicinal Chemistry. This 29th edition will be held on the 4th and 5th of June in the beautiful city of Spa located in the heart of Belgium Ardennes.
This two-day symposium aims to promote the meeting between medicinal chemists mainly from France and Belgium. The JFB are renowned for advanced science, conviviality, and outstanding opportunities for senior and young scientists to exchange knowledge.


11–12 June 2015 Molecular Diagnostics Summit

San Diego, CA, USA

GTCbio’s Molecular Diagnostics Summit will take place on June 11-12 in San Diego, CA. The summit is comprised of 4 parallel conferences: Cancer Markers & Circulating Tumor Cells, Pathology Diagnostics, Companion Diagnostics, and Point of Care Diagnostics.


26–27 August 2015 23rd Conference of the Groupement des Pharmacochimistes de l'Arc Atlantique (GP2A) will be organized as part of the 1st European Conference on Therapeutic Targets and Medicinal Chemistry

Muenster, Germany

"Groupement des Pharmacochimistes de l'Arc Atlantique" (GP2A) or Group of Medicinal Chemists of the Atlantic Arc is a study group on research and teaching in Medicinal Chemistry, which was created in 1992. It gathers medicinal chemists, mainly working in Faculties of Pharmacy and located in the different regions of the Atlantic Arc in the United Kingdom, France, Spain and Portugal. More recently, this grouping has welcomed new members who do not belong stricto sensu to this area (such as Lille, Saarbrucken, Düsseldorf), in the framework of the GP2A network. This Grouping constitutes a focus for the exchange of ideas among scientists (including undergraduates) interested in basic research in medicinal chemistry but also in special areas of research in drug design, including combinatorial chemistry, quantitative structure-activity relationships and molecular modelling. GP2A gives an opportunity, especially to young scientists, to strengthen and extend their collaboration and exchange programs. The circle is open to external participation and is mainly constituted on the basis of previously existing bilateral co-operations between various laboratories. At the instigation of the starting core, it was decided to hold a scientific meeting each year in the shape of the GP2A Conferences. Every year, besides senior lecturing, the GP2A organisers wish to devote a large number of the conferences to short student oral presentations.


26–27 August 2015 1st European Conference on Therapeutic Targets and Medicinal Chemistry

Muenster, Germany

It is our pleasure and privilege to cordially invite you to the 1st European Conference on Therapeutic Targets and Medicinal Chemistry (TTMC). This conference will combine the 23rd conference of GP2A with the 3rd conference of ChemBioInteractions. The major topics are anticancer drugs, new targets, protein-protein interaction inhibitors and novel tools.
Besides being a forum for intense discussion and scientific exchange, the major aim of the conference is to provide a platform for young scientists to present their research. Beside lectures of senior speakers and junior speakers, there will be sessions for flash presentation of contributions from young scientists. We strongly encourage the submission of abstracts for posters and oral presentations by PhD students and young Post-Docs. There will be awards for both, oral and poster presentations.


3–4 September 2015 Cancer diagnosis & Therapy Congress

London, UK

MarketsandMarkets Conferences (MnM Conferences) is delighted to announce the inaugural Cancer Diagnosis & Therapy Congress to be held on September 3-4, 2015 London, UK focusing on the theme of “Advancement in Cancer diagnosis, treatment and challenges in organ specific cancer treatment”. The two day program will address key concerns such as cancer Immunotherapy, molecular targeted therapy, metabolomics in cancer tumour assessments & profiling, nanotechnology in cancer therapy, hormone therapy, stem cell Transplantation, surgical oncology, epigenetics, cancer genomics, cancer biomarkers, bio banking, non-invasive cancer diagnostics, organ specific cancers, cancer epidemiology and clinical trial in cancer research. Major segments to be discussed : • Advanced Cancer Detection, Diagnosis Methods and Technologies • Novel Approaches to Cancer Therapy • Emerging Challenges in Organ Specific Cancers Research


10–12 September 2015 6th BBBB Conference on Pharmaceutical Sciences

Helsinki, Finland

The 2015 BBBB Conference will offer a versatile scientific program, in order to attract scientists from all fields of pharmaceutical sciences. Like its predecessors, the conference will offer opportunities to exchange scientific ideas and create networks between people from academia, industry and regulatory authorities as well as between young and established scientists and professionals. The program consists of lectures from well-known experts in different areas of pharmaceutical science but there is also a special emphasis to give younger researchers an opportunity to present their research in an international environment.


10–12 September 2015 AGRR 2015

Universitätsklinikum Erlangen, Germany

23. Jahrestagung der Arbeitsgemeinschaft Radiochemie / Radiopharmazie


11–14 October 2015 Cytokines 2015

Bamberg, Germany

This Annual Meeting of the International Cytokine and Interferon Society provides an outstanding forum for investigators in basic science and clinical research to present their most recent findings on the role of cytokines in infectious diseases, inflammation, cancer, autoimmunity and novel therapeutic interventions.


2–27 November 2015 1st International Electronic Conference on Medicinal Chemistry


Pharmaceuticals is proud to organize and sponsor the first International Electronic Conference on Medicinal Chemistry. Contributions dealing with any discipline promoting research in drug discovery and development will be welcome. It will allow you to present your recent results to the scientific community and to have the opportunity to start fruitful exchanges of information with academic and industrial groups from all over the world. Participation, as an author or a visitor, is free of charge.


1–3 December 2015 Portuguese Chemical Society: Thinking Organic and Medicinal Chemistry in an inspiring atmosphere

Porto, Portugal

The Organic and Medicinal Chemistry divisions of the Portuguese Chemical Society (SPQ) are honoured to invite you to participate in their joint meeting next December (1st – 3rd) in Porto, Portugal. For the first time under the auspices of SPQ, the competences of these two important fields of Chemistry are brought together into a single event, to highlight complementarities and to promote new synergies.


14–15 December 2015 RICAI 2015: 35th Interdisciplinary Meeting of Anti-infective Chemotherapy

Palais des Congrès de Paris, France

For 35 years, the RICAI has been the largest European French-language congress in the field of global anti-infective therapy.
This meeting brings together about 1,500 members of the community of infectious diseases, both researchers and clinicians and a large range of medical professionals.
The RICAI congress has a double aim:
Infection Chemotherapy: where the focus is on the drug and its action on the microbes (bacteria, fungus, virus or vibrio), as opposed to focusing on patient care for example.
Interdisciplinary: the concept of the congress is to provide the opportunity for communication and exchange of ideas between laboratories and therapists, and fundamentalists and clinicians.
The RICAI congress annually gathers free papers, providing plenary lectures, symposia and other thematic sessions, aimed at promoting exchange, meetings and information in the clinical microbiology, infectious diseases and anti-infective chemotherapy domains.

Depuis 35 ans, la RICAI est le plus important congrès européen de langue française dans le domaine de la thérapeutique anti-infectieuse globale.
Cette réunion rassemble environ 1500 membres de la communauté de l’infectiologie, tant des chercheurs que des cliniciens et des personnalités appartenant aux structures réglementaires d’enregistrement.
La RICAI poursuit un double objectif :
Chimiothérapie anti-infectieuse : le focus est mis sur le médicament et son action sur le microbe (bactérie, mycose, vibrion ou virus), par opposition à un focus sur la prise en charge du patient par exemple.
Interdisciplinaire : le concept de la réunion est de faire dialoguer les laboratoires et les thérapeutes, les fondamentalistes et les cliniciens
La RICAI alterne chaque année communications libres, conférences plénières, symposia et autres sessions à thèmes, ayant pour but de favoriser rencontres, échanges et informations dans les domaines de la microbiologie clinique, de l'infectiologie et de la chimiothérapie anti-infectieuse.


23–24 February 2016 Early Clinical Development

Amba Hotel Marble Arch, London, UK

Early Clinical Development is an open forum for exchanging knowledge between Industry, Academia and the Regulators. With brand new formats, increased audience participation, two site visits and an exceptional speaker faculty, it is a must attend for early phase clinical professionals. For more information visit


11–13 May 2016 European Pharma Summit 2016

Berlin, Germany

We invite you to attend the European Pharma Summit 2016, which will take place on May 11-13, 2016 in Berlin, Germany. This event seeks to create a forum for colleagues across multiple disciplines, as well as from both private and public sectors, to gather and exchange ideas. Delegates from pharmaceutical organizations, biotech companies, and leading academic institutions will gather over the course of four days to listen to presentations on the hottest topics in drug discovery and network with both new and old colleagues.


25–27 May 2016 30th France-Belgium meeting of Pharmacochemistry

Amboise, France

30th France-Belgium meeting of Pharmacochemistry
Amboise, France, May 25-27th 2016

The “France-Belgium meeting of Pharmacochemistry” is a recognized annual meeting on Medicinal Chemistry. This 30th edition will be held on the 25th to the 27th of May in the beautiful city of Amboise located in the “Centre – Val de Loire” Region of France.

This symposium aims to promoting the meeting between medicinal chemists mainly from France and Belgium. The JFB are renowned for advanced science, conviviality, and outstanding opportunities for senior and young scientists to exchange knowledge. The scientific program will include one “Grand Public” conference, one opening conference and 7 plenary lectures by internationally recognized scientists.

Industrial and academic scientists will give talks mainly in imaging (TEP), oncology and CNS disorders topics.

An important part of the program is devoted to open lectures (11 oral communications) giving the opportunity for young scientists to present their research.

The official language for the oral communications will be English.

The deadline for the registration is April 15, 2016 - The dead line for abstracts submission is May 1, 2016.

The website is http://jfb2016.sciencesconf.org/


24–25 June 2016 Aptamers in Bordeaux 2016

Bordeaux, France

Aptamers in Bordeaux is an international conference on Aptamer Biology, Chemistry and Technologies. Core subjects are listed below:

• in vitro selection methodology
• Analytical applications
• Imaging
• Bio- and nano-technology
• Riboswitches
• Diagnostics
• Therapeutics


28 August–1 September 2016 13th European Biological Inorganic Chemistry (EuroBIC 13)

Budapest, Hungry

In 1992 European bioinorganic chemists and biochemists decided to create the conference series EUROBIC (European Biological Inorganic Chemistry Conference) to bring together 300-400 participants for exchanging their latest results and different points of view in the field of metalloenzymes, metalloproteins, interactions of DNA with inorganic complexes, toxicology of metal ions, medicinal use of metal complexes, etc. EUROBIC and ICBIC (International Conference on Biological Inorganic Chemistry), both biennially meetings, are the classical conferences to obtain top-level information int he field of biological inorganic chemistry.
The first Conference was held in Newcastle in 1992, while the venue of the previous Conferences are Wroclaw 2006, Thessaloniki 2008, Barcelona 2010, Granada 2012, Zurich 2014. We line up into this illustrious series. Budapest organises the EUROBIC13 in 2016.
The scientific program will include invited plenary (8), keynote and session lectures (25-30) and contributed papers (40) and posters.
The following topics will be covered: Biocoordination chemistry: complexes of peptides, nucleotides and relatides ligands, Bioinorganic Chemistry and Nanotechnology; Biomineralization; Metals in medicine; Metal in the Environment; Metabolism of Metal ions; Metal ion sensing in Biology, Metalloproteins; Metals in the Brain; Metal ion interactions with nucleic acids; Spectroscopy and diffraction, Other topics.
We look forward to meeting you in Budapest in 2016.


6–9 September 2016 8th International Conference on Protein Kinase CK2

Homburg, Germany

Protein kinase CK2 is a serine/threonine kinase which is highly conserved in evolution. Knock-out experiments have shown that this enzyme is absolutely necessary for cell viability. The enzyme is highly expressed in rapidly proliferating cells which goes along with an elevated enzyme activity. Protein kinase CK2 is involved in a broad range of signaling pathways regulating proliferation, differentiation, apoptosis or senescence. Recent advances towards the characterization of the three dimensional structure of protein kinase CK2 and its subunits will undoubtedly yield important new insights into its regulation and functions of CK2. Moreover, with two inhibitors of the enzyme in clinical trials phase II at current, human protein kinase CK2 appears as an emerging target for cancer diseases.


12–15 September 2016 Modern Drug Discovery & Development Summit (M3D)

Boston, MA

The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research and current developments in the field. The Summit will feature six conferences that will cover the latest hot topics in drug discovery:
11th Drug Design & Medicinal Chemistry
3rd Cell & Gene Therapy
Drug Delivery & Controlled Releases
7th Non-Coding RNA & RNAi Therapeutics
4th GPCR in Drug Discovery
Cell Culture & Cell Line Development


13–16 September 2016 Modern Drug Discovery & Development Summit (M3D)

Boston, MA

We invite you to attend the Modern Drug Discovery & Development Summit (M3D), which will take place September 13-16, 2016 in Boston, MA. The summit will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the various research and current developments in the field.

For more informations, please visit the website.


25–28 September 2016 4th Conference on Innovation in Drug Delivery: Site-Specific Drug Delivery

Antibes-Juan-les-Pins (close to Nice), France

The fourth edition of the Conference on Innovation in Drug Delivery will be organized jointly by ADRITELF (Associazione Docenti Ricercatori Italiani di Tecnologia e Legislazione Farmaceutische), Italy, and APGI (International Society of Drug Delivery Sciences and Technology), France, in Antibes-Juan-les-Pins (France) from 25 to 28 September, 2016. The symposium topic will be “Site-Specific Drug Delivery”. It will consist in plenary and invited lectures as well as short oral presentations. The conference will also host an industrial exhibition as well as technical presentations, offered to the sponsors who would like to introduce their technology/methodology by an oral presentation.


1–30 November 2016 2nd International Electronic Conference on Medicinal Chemistry


Pharmaceuticals is proud to organize and sponsor the Second International Electronic Conference on Medicinal Chemistry. Contributions dealing with any discipline promoting research in drug discovery and development will be welcome. It will allow you to present your recent results to the scientific community and to have the opportunity to start fruitful exchanges of information with academic and industrial groups from all over the world. Participation, as an author or a visitor, is free of charge.


20–21 March 2017 Revolutionizing Next-Generation Sequencing (2nd edition)

Antwerp, Belgium

Enabled by better cost-performance curves and novel technology developments, Next-Generation Sequencing technologies keep on pushing the boundaries of our scientific knowledge. The NGS-field is still expanding and to take advantage of new opportunities offered by these technologies in life sciences, VIB Conferences will host the second edition of Revolutionizing Next-Generation Sequencing: Tools and Technologies.
After a sold-out 2015 edition, RNGS17 will look at emerging tools and approaches for:
• Large-scale Sequencing
• Applications for Current and Emerging Next-Generation Sequencing Platforms
• Single-Cell Genomics
• Epigenetics
• Next-gen Transcriptomics technologies
• Ultra-long reads and Assembly
• Computational genomics and data analysis

In addition to a great scientific and technology program, the conference will provide ample opportunities to network during the breaks, poster sessions, the conference dinner and our ‘Meet the Expert’ session!

• Abstract submission deadline: 20 January 2017
• Early Bird: 06 February 2017
• Finale Deadline: 06 March 2017


11–12 April 2017 Aptamers 2017

Oxford, UK

Aptamers 2017 – the 4th annual meeting of the International Society on Aptamers – will bring together academic and industrial aptamer researchers and solution providers from across the globe. The symposium will address therapeutic, diagnostic, analytical as well as basic research applications of aptamers and invites oral and poster abstracts. We particularly encourage final year doctoral students and early/mid-career postdoctoral researchers/junior group leaders to submit oral abstracts, as we believe this event will provide their research an excellent exposure, critical analysis by attending senior researchers and new career opportunities. Please contact us on AptamersOxford@gmail.com, or visit our website at http://libpubmedia.co.uk/aptamers-2017, should you require any further information.

Aptamers 2017 will be co-hosted with our 3rd symposium on antisense and therapeutic oligonucleotides, Oligo 2017 Oxford (http://lpmhealthcare.com/oligo-2017-oxford), on 10th April. We very much look forward to welcoming you to Oxford in April.


31 July–4 August 2017 18th International Conference on Biological Inorganic Chemistry (ICBIC18)

Florianopólis, Brazil

Welcome to the 18th International Conference on Biological Inorganic Chemistry - ICBIC18, to be held from July 31st to August 4th in Florianópolis, Brazil (www.icbic18.weebly.com).

Chair: Ademir Neves (Brazil)
Co-Chairs: Ana Maria da Costa Ferreira (Brazil) & Alejandro J. Vila (Argentina)

Florianópolis is the capital and second largest city of Santa Catarina state in the Southern region of Brazil. It is composed of one main island, the Island of Santa Catarina, a continental part and the surrounding small islands. The city is famous for its natural beauties and life quality – the best among all the Brazilian capitals. There are several beaches spread throughout the island and the continental part. Find other attractions to visit, such as lagoons, the historical center, Azorean districts, Portuguese forts, and the city postcard: the Bridge.

Confirmed Plenary Speakers
Angela Casini, Cardiff University, UK
Chris Orvig, Univ. of British Columbia, CA
Shinobu Itoh, Osaka University, JP
Nicholas P. Farrell, Virgina Commonwealth Univ., US
Vincent Pecoraro, University of Michigan, US
Ohara Augusto, Universidade de São Paulo, BR
Christian Hartinger, (SBIC award), University of Auckland, NZ


27–28 September 2017 15th Annual Pharmaceutical IT Congress

London, UK

Oxford Global Conferences are proud to present the 15th Annual Pharmaceutical IT Congress co-located with our Artificial Intelligence in Drug Development Congress, taking place on the 27-28 September 2017 in London.

200 delegates from world renowned academic institutions, hospitals, global pharmaceutical organisations and leading biotechnology companies

40 presentations and case studies focusing on the key developments in in Big Data and analytics, lab informatics, collaboration, digital health, wearable technologies, blockchain technology, lab automation and challenges in data privacy.

Including 4 interactive streams:

  • Getting the most out of big data in R&D IT
  • Translational Science and Medicine
  • Data Management, Real-World Evidence & Real-World Data
  • IT Solutions

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities. This event is co-located with our Artificial Intelligence in Drug Development Congress.

Free Pre-Congress Webinars

Workflow Management in Analytical R&D Labs
Hosted by Jan Hauβ, Merck KGaA.

Click here to register today, for free.

Pre-Competitive Collaborations: Realising Benefits and Overcoming Challenges
Hosted by Christopher Hart, AstraZeneca and Nigel Hughes, Janssen Research and Development.

Click here to register today, for free.

For further information, click here: http://bit.ly/1CZv606


1–30 November 2017 3rd International Electronic Conference on Medicinal Chemistry Online


Further to the success of the two first editions, Pharmaceuticals, a peer-reviewed journal edited by MDPI, is proud to organize and sponsor the 3rd International Electronic Conference on Medicinal Chemistry. Contributions dealing with any discipline promoting research in drug discovery and development will be welcome.

The conference will be held online (www.sciforum.net/conference/ecmc-3) from November 1–30, 2017. It will enable you to share your recent results with scientists of academic and industrial groups from all over the world.

Participation, as an author or a visitor, is ABSOLUTELY FREE (simply create an account on the home page). Abstracts of the presentations will be published, upon authorization of the authors, in a meeting report after the conference.

On behalf of our dynamic editorial staff and active scientific committee, we warmly invite you to join us during this third edition and we look forward to posting your contributions.

For further information, click here: http://sciforum.net/conference/ecmc-3.


Back to Top